Khiron Life Sciences (Khiron Life Sciences) Total Stockholders Equity : $20.32 Mil (As of Sep. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Khiron Life Sciences Total Stockholders Equity?

Khiron Life Sciences's Total Stockholders Equity for the quarter that ended in Sep. 2022 was $20.32 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Khiron Life Sciences's Book Value per Share for the quarter that ended in Sep. 2022 was $0.09. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Khiron Life Sciences's Debt-to-Equity for the quarter that ended in Sep. 2022 was 0.09.

Khiron Life Sciences Total Stockholders Equity Historical Data

The historical data trend for Khiron Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences Total Stockholders Equity Chart

Khiron Life Sciences Annual Data

Trend

May12

May13

May14

May15

May16

May17

Dec18

Dec19

Dec20

Dec21

Total Stockholders Equity

Get a 7-Day Free Trial

-0.08

19.01

53.19

49.36

26.04

Khiron Life Sciences Quarterly Data
	Nov17	Feb18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Total Stockholders Equity	Get a 7-Day Free Trial															43.41	26.04	23.31	23.33	20.32

Khiron Life Sciences (OTCPK:KHRNF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Khiron Life Sciences's Book Value per Share for the quarter that ended in Sep. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(20.319	-	0)	/	217.14
	=	0.09

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Khiron Life Sciences's Debt-to-Equity for the quarter that ended in Sep. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.919	+	1.003)	/	20.319
	=	0.09

Khiron Life Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Khiron Life Sciences (Khiron Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRNF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5

Website

https://www.khiron.ca

Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.